Meet Dr Lisanne Spenkelink
Sepsis kills 11 million people annually - that's around one in 5 deaths. At UOW's Molecular Horizons, Dr Lisanne Spenkelink and her team are working to develop ultra-rapid, low-cost diagnostics that could help identify sepsis before symptoms appear.
Sepsis kills about 11 million people annually. That is about one in five deaths globally. The disease progression with sepsis is very, very rapid. My goal is simple, to make sepsis a disease that we can stop before it even starts. The primary outcome would be a device that can be deployed in hospitals, but also remote clinics that can diagnose sepsis fast, accurately, and is cheap.
I have over a decade's worth of experience in the development and use of single molecule methodologies. And in the last couple of years, we have developed these sensors that are already being used internationally that can really detect single biomarkers. The first thing that's new and different is the methodology. Think about trying to detect these sepsis biomarkers, which are the signals in our blood that indicate that something is wrong. When sepsis symptoms haven't occurred, those biomarkers are present at very, very low amounts.
And it's like comparing it to looking for a needle in a haystack. So to be able to do this is going to change how we diagnose sepsis in young children.